T
here is growing evidence that several estrogen-dependent effects are induced through cell membrane-associated signaling rather than by the classic nuclear receptor route of steroid hormone action. [1] [2] [3] In the vasculature, reported rapid effects of estrogen such as acute vasodilatation in vivo 4, 5 and estrogen receptor (ER) ␣-mediated release of nitric oxide (NO) from endothelial cells in vitro 6, 7 represent examples of apparent nongenomic estrogenic effects as they are observed within minutes after the application of estradiol. Recent evidence suggests not only that ER-␣ receptors are present in the cell membrane, but that they can translocate into the nucleus in response to extracellular stimuli such as estradiol per se or ligand-independent activators of ER-␣ (eg, epidermal growth factor, serum). 8 The inhibitory effects of estrogens on vascular smooth muscle cell (VSMC) growth are well established, 9, 10 and presumably exert some protective vascular effects. 11, 12 Contrary to the effects of estadiol on vascular contractility and NO release, estrogenic modulation of VSMC growth is expressed in the course of several days and hence, cannot be considered as a rapid effect. Furthermore, although the precise mechanism of estradiol-induced inhibition of VSMC growth remains elusive; it appears that this effect persists in ER-␤, but not in ER-␣ knockout mice. 13, 14 We have previously reported that estradiol and some phytoestrogens exert a biphasic effect on human VSMC growth, such that low concentrations (in the range observed in men and postmenopausal women) increase, whereas higher concentrations, characteristic of premenopausal women, decrease DNA synthesis in cultured VSMC. 10, 15, 16 The fact that there is an inhibitory effect of estradiol on VSMC proliferation that possibly depends on membrane-associated signaling is suggested because it requires activation of mitogen-activated protein (MAP)-kinase and is blocked by inhibition of MAP-kinase-kinase. 17 However, direct evidence for the involvement of membrane receptors in the inhibitory effect of estradiol on VSMC replication has not been thus far presented. The present study was undertaken to determine whether or not estrogenic modulation of DNA synthesis in human vascular cell is exerted by putative estrogenic membrane receptors.
Methods

Regents
Enhancement solution for measuring europium fluorescence was purchased from Wallac (Turku, Finland). Steroids, chemicals, and the creatine kinase kit were from Sigma (St. Louis, MO). The labeling reagent N-1(p-isothiocyanatophenyl)-diethylene-tri-N1,N2,N3,-tetraacetate chelated with europium (activated Eu-chelate) was kindly provided by Dr. I. Hemmila Wallac (Turku, Finland). Cy3.5 bis reactive dye was purchased from Amersham Pharmacia Biotech (Buckinghamshire, United Kingdom).
Preparation of Estradiol Macromolecular Conjugates
Estradiol-6-(O)-carboxymethyl oxime (E 2 -6-CMO) 18 was conjugated to bovine serum albumin (BSA) and ovalbumin (Ov) through a two-step reaction, as described previously. 19 Conjugates of daidzein with keyhole limpet hemocyanin (KLH) 7-(O)-carboxymethyl daidzein (CD-KLH) and 6-carboxymethyl genistein-KLH (CG-KLH) were prepared as previously described by Kohen et al. 19, 20 Ultraviolet analysis of the E 2 -BSA and E 2 -ovalbumin indicated that the conjugates contained 10 moles of hapten per mole of protein. The TLC analysis of these conjugates showed that the conjugates did not have traces of free E 2 or E 2 -6-CMO.
Preparation of Cy3.5-Labeled Steroid BSA Conjugates
The membrane impermeant steroid conjugates E 2 -6-CMO-BSA (E 2 -BSA) (1 mg) and 4-chloro-androstenedione-3-(O)-carboxymethyl oxime BSA (CLAD-BSA, 1 mg, prepared in our laboratory 21 ; used for negative control) were labeled with the reactive dye bis Cy3.5 according to the instructions of the manufacturer. The labeled protein contained 1 mole of the dye per mole of protein.
Cell Culture
Vascular smooth muscle cells were prepared from human umbilical artery as previously described with minor modifications. 10, 22 Cells were used only at passages 1 to 3 when expression of smooth muscle ␣-actin was clearly demonstrated.
The ECV 304 (E304) cells, an endothelial cell line derived from a human umbilical vein, were purchased from American Type Culture Collection (Manassas, VA) and grown as described previously 10, 15, 16 in medium 199 containing 10% fetal calf serum, glutamine, and antibiotics.
Assessment of DNA Synthesis
Cells were grown until subconfluence and then treated with various hormones or agents, free or conjugated compounds, as indicated. Twenty-two hours after the exposure to these agents, [ 3 H]thymidine was added for 2 h. 10, 15, 16 Cells were then treated with 10% ice-cold trichloroacetic acid (TCA) for 5 min and washed twice with 5% TCA and then with cold ethanol. The cellular layer was dissolved in 0.3 mL of 0.3 N NaOH, samples were aspirated, and [ 3 H]thymidine incorporation into DNA was determined by counting in a Packard Tri Carb 2100TR liquid scintillation analyzer (Meriden, CT).
Creatine Kinase Extraction and Assay
Cells were treated for 4 h, the optimal time observed from previous studies, 10, 15, 16 with the various hormones and agents as specified, and were then scraped off the culture dishes and homogenized by freezing and thawing three times in an extraction buffer as previously described. 10, 15, 16 Supernatant extracts were obtained by centrifugation of homogenates at 14,000 g for 5 min at 4°C in an Eppendorf microcentrifuge (Hamburg, Germany). Creatine kinase activity (CK) was assayed by a coupled spectrophotometric assay described previously. 10, 15, 16 Protein was determined by Coomasie blue dye binding using BSA as the standard.
Immunofluorescence Studies of Membrane Estrogen-Binding Sites
Cells (5 ϫ 10 3 cells/chamber) were grown on Lab-TekII chamber slide system (Nalge Nunc International, Naperville, IL). After reaching subconfluence, cells were washed with magnesium and calcium-free phosphate buffered saline (PBS) for 5 min at 37°C. The PBS was then aspirated and cells were placed at 4°C in a shaking bath for 30 min with Cy3.5-labeled E 2 -BSA (15 L) or Cy3.5-labeled CLAD-BSA (15 L). After staining, the cells were washed five times with cold PBS containing 1% BSA and fixed for 10 min at 4°C with 3% para-formaldehyde in PBS. After one washing in PBS, the stained cells were mounted with Elvanol mounting solution for fluorescent microscopic and confocal fluorescent microscopic evaluation.
Assessment of Total MAP-Kinase Activity
To evaluate the possibility that membrane-impermeant estrogenic ligands activate MAP-kinase (MAPK) activity as free E 2 , we determined total MAPK in treated vascular cells. General anti-MAP kinase rabbit antibody [ERK-2 (c-14), sc-154] was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Activated MAP-kinase antibody was purchased from Sigma. Enhancement solution was purchased from Wallac. The europium-chelating agent was a generous gift from I. Hemmilla. The MAP-kinase-kinase inhibitor UO126 was purchased from Alexis (Lausen, Switzerland). Each treatment was performed in quadruplet. After 15 min of exposure to the various free or macroprotein-bound ligands, cells were washed twice with calcium-and magnesium-free cold PBS. Subsequently, 0.3 mL of lysis buffer was added to each plate. Lysis buffer consisted of 20 mmol/L HEPES at pH 7.5, containing 150 mmol/L NaCl, 1% triton-X 100, 10% glycerol, 1 mmol/L EDTA, 1 mmol/L EGTA, 10 mmol/L NaF, 10 mmol/L ␤-glycerol phosphate, 2 mmol/L phenylmethylsulfonyl fluoride, and protease inhibitors (1 mmol/L benzamidine, 2 nmol/L sodium vanadate, 10 g/mL leupeptin, 10 g/mL aprotinin, and 10 g/mL pepstatin). The plates were gently agitated at 4°C for 10 min. The cells were then scraped from each plate, and transferred to Eppendorf tubes. After centrifugation of the tubes at 4°C for 10 min at 14,000 g, the supernatants (lysates) containing total cell extracts were removed. The cell lysate corresponding to each treatment (which was done in triplicate) was combined and divided into three aliquots. One aliquot was used for protein determination with Coomassie blue using BSA as the standard.
Two-Site Assay for Assessment of MAP-Kinase Activity
For the performance of the two-site MAP-kinase assay, which assesses the net accumulation of phosphorylated MAPK resulting from both MAPK-kinase and MAPKphosphatase activity, microtiter strips (Labsysterms, Oy, Helsinki, Finland) were coated for 70 h at 4°C with the general anti-MAP kinase antibody (2.5 g/mL PBS at pH 7.4, 200 L /well). The antibody solution from each well was then decanted, and the microtiter strips were blocked with 200 L/well blocking buffer (PBS containing 2% BSA) for 2 h at room temperature. The microtiter strips were then washed twice with wash solution, 23 after which the cell lysates were transferred (100 L/well) in triplicate to the microtiter wells. Assay buffer 23 (100 L) was then added to each well and the strips were incubated overnight at 4°C and washed three times. Subsequently, europiumlabeled, activated anti-MAP kinase antibody (192 ng/well in 200 L of assay buffer) was added, and the strips were incubated under shaking conditions for 2 h at room temperature. The strips were then washed four times and processed for time-resolved fluorescence as described previously. 23 
Expression of ER-␣ and ER-␤ in VSMC
RNA was extracted from cultured VSMC cells, which were shown before 15 to contain ER-␣ and ER-␤ by Western blot analysis, and subjected to reverse transcription as previously described. 22 For ER-␣, we used 5 L of complementary DNA in the reaction mixture with the primers 5Ј-AATTCTGACAATCGACGCCAG-3Ј (forward) and 5Ј-GTGCTTCAACATTCTCCCTCCTC-3Ј (reverse), for 30 cycles at 94°C for 30 sec, at 57°C for 30 sec, and at 72°C for 1 min. For ER-␤, the same amount of cDNA was used with the primers 5Ј-TGCTTTGGTTTGGGT-GATTGC-3Ј (forward) and 5Ј-TTTGCTTTTACTGTC-CTCTGC-3Ј (reverse) for 30 cycles at 94°C for 30 sec, at 58°C for 30 sec, and at 72°C for 1 min (Rutherford et al 24 ). The ER-␣ and ER-␤ cDNA were used as standard controls.
Statistical Analysis
Differences between the mean values obtained from the experimental and the control groups were evaluated by analysis of variance (ANOVA). A P value Ͻ .05 was considered significant.
Results
Effect of E 2 -BSA on DNA Synthesis in VSMC and ECV 304 Cells
When cells were incubated with increasing concentrations of E 2 or E 2 -BSA and DNA synthesis was measured, the following results were obtained. In VSMC, at low concentration E 2 stimulated DNA synthesis, but high concentrations, it had an inhibitory effect. The E 2 -BSA induced similar effects, although higher concentrations were required. In ECV 304 cells, the dose-dependent stimulation of DNA synthesis observed with E 2 was maximal at 300 nmol/L, with a decline at 3000 nmol/L. This effect was not mimicked by E 2 -BSA, which was completely inactive (Fig. 1) .
Effect of E 2 -BSA on CK Specific Activity in VSMC and in ECV 304 Cells
When cells were incubated with increasing concentrations of E 2 , there was a dose-dependent stimulation of CK specific activity in VSMC and ECV 304 cells, in which the maximal response was observed at 30 nmol/L with a decline at 300 and 3000 nmol/L. In both cell types, however, the dose-dependent stimulation of CK specific activity by E 2 was not mimicked by E 2 -BSA, which was completely inactive (Fig. 1) .
Effect of CG-KLH and CD-KLH on DNA synthesis in VSMC and in ECV 304 Cells
When cells were incubated with increasing concentrations of CG 20 or CD 19 and CG-KLH or CD-KLH, 20 and DNA synthesis was measured, the following results were obtained. In both VSMC and ECV 304 cells, CG and CD dose-dependently stimulated [ 3 H]thymidine incorporation. The CG-KLH and CD-KLH elicited similar effects in VSMC, although higher doses were needed. In ECV 304 cells, the dose-dependent stimulation of DNA synthesis by CG and CD was not mimicked by CG-KLH or CD-KLH, which were completely inactive, exerting no statistically significant changes (Tables 1 and 2 ).
Effect of CG-KLH and CD-KLH on CK Specific Activity Synthesis in VSMC and in ECV 304 Cells
When cells were incubated with increasing concentrations of CG or CD and CG-KLH or CD-KLH and CK specific activity was measured, the following results were obtained. In both VSMC and ECV 304 cells, CG and CD dose-dependently stimulated CK specific activity. The CG-KLH and CD-KLH were not able to mimic the effects of CG or CD, and were completely inactive in both cell types (Tables 1 and 2 ). 
Expression of ER-␣ and ER-␤ in VSMC
Effect of Macroprotein-Bound Estrogenic Ligands on Total MAPK in VSMC and the effect of MAPK-Kinase Inhibition on Estrogenic Modulation of VSMC Growth
The effects of E 2 , E 2 -BSA, and CG-KLH on total activated MAPK activity in VSMC are summarized in Fig. 5 . As shown, free E 2 as well as either one of the estrogenic compounds conjugated with a membrane impermeable macroprotein, E 2 -BSA and CG-KLH, induced a significant stimulation of MAPK activity. Basal MAPK activity Table 1 . was reduced in the presence of the MAPK-kinase inhibitor UO126 by 28% Ϯ 24%, but the inhibitor blocked completely the hormonal stimulation of MAPK activity (Fig.  5) . The MAPK-kinase inhibitor UO126 reduced baseline [ 3 H]thymidine incorporation (Ϫ38% Ϯ 17%) and inhibited both E 2 -and E 2 -BSA-induced suppression of DNA synthesis. In addition, UO126 inhibited the increase in [ 3 H]thymidine incorporation elicited by CG-KLH (Fig. 5) .
FIG. 2. Estrogen receptors ␣ (ER␣) and
In contrast, MAPK-kinase inhibition had no effect on the increase in CK specific activity induced by E 2 , E 2 -BSA, or CG-KLH, with no effect on CK activity by itself (36% Ϯ 25%; Fig. 5 ).
Discussion
The results of this study suggest that E 2 inhibits human VSMC cell growth through an interaction with membranebinding sites, which recognize, in addition to E 2 , several phytoestrogens, but do not interact with dihydrotestosterone. First, the cell membrane impermeant ligand E 2 -BSA induced the same inhibitory effect on DNA synthesis in VSMC as E 2 per se, albeit at 10-fold higher concentrations (Fig. 1) . This may be due to the lower affinity of E 2 -6-CMO, the E 2 derivative present in E 2 -BSA, compared with E 2 per se. In addition, association with the macroprotein may somewhat hinder the binding of E 2 to its putative membrane receptor, while still allowing receptor activation in terms of the effects on VSMC growth. In contrast, the same ligand, apparently incapable of entering the cell after its association with the cell membrane receptor, was entirely ineffective in inducing CK activity, a classic genomic marker of estradiol's effect (formerly termed estradiol-induced protein). Of note is also the finding that although E 2 -BSA inhibited VSMC cell growth, it had no effect on cell proliferation in the endothelial ECV 304 cells, in which E 2 itself induced a substantial and dosedependent increase in DNA synthesis. Further heterogeneity in what is routinely presumed as "estrogenic effects" is exemplified by the effects of two phytoestrogen derivatives, carboxymethyl genistein and carboxymethyl daidzein and their respective macroprotein conjugates CG- 
